CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls

ISSN： 1357-0560

Source： Medical Oncology, Vol.28, Iss.1, 2011-03, pp. : 182-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies

Experimental and Therapeutic Medicine, Vol. 4, Iss. 5, 2012-01 ,pp. : 938-948

Spandidos Publications

Access to resources Recommend Favorite

TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls

By Gu Dongying

Breast Cancer Research and Treatment, Vol. 123, Iss. 3, 2010-10 ,pp. : 857-861

Springer Publishing Company

Access to resources Recommend Favorite

Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls

By Mao Chen

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 259-265

Springer Publishing Company

Access to resources Recommend Favorite

SULT1A1 R213H polymorphism and breast cancer risk: a meta-analysis based on 8,454 cases and 11,800 controls

By Wang Zhanwei Fu Yuanyuan Tang Chunbo Lu Su Chu Wen-ming

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 193-198

Springer Publishing Company

Access to resources Recommend Favorite

CYP1A2 rs762551 polymorphism contributes to risk of lung cancer: A meta-analysis

By Ma Zheng Guo Wei Gong Taiqian Niu Hui-Jun Wang Ru-Wen Jiang Yao-Guang

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2253-2257

Springer Publishing Company

Access to resources Recommend Favorite